-
Signature
-
/s/ Christian Kuhlen, attorney-in-fact
-
Issuer symbol
-
ORIC
-
Transactions as of
-
12 Jun 2025
-
Net transactions value
-
-$3,000
-
Form type
-
4
-
Filing time
-
13 Jun 2025, 19:38:23 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Piscitelli Dominic |
Chief Financial Officer |
C/O ORIC PHARMACEUTICALS, INC., 240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO |
/s/ Christian Kuhlen, attorney-in-fact |
13 Jun 2025 |
0001695028 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ORIC |
Common Stock |
Sale |
$3,000 |
-300 |
-0.29% |
$10.00 |
101,817 |
12 Jun 2025 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: